Cipro iv (ciprofloxacin) is a synthetic antimicrobial agent for intravenous (iv) administration. ciprofloxacin, a fluoroquinolone, is 1 cyclopropyl 6 fluoro 1,4 dihydro 4 oxo 7 (1piperazinyl) 3quinolinecarboxylic acid. its empirical formula is c 17 h 18 fn 3 o 3 and its chemical structure is:. Cipro® iv (ciprofloxacin) for intravenous infusion . 11 11 . warning: fluoroquinolones, including cipro® iv, are associated with an increased risk of tendinitis and tendon rupture in all ages. Cipro iv is indicated for treatment of plague, including pneumonic and septicemic plague, due to yersinia pestis (y. pestis) and prophylaxis for plague in adults and pediatric patients from birth to 17 years of age. efficacy studies of ciprofloxacin could not be conducted in humans with plague for feasibility reasons. Ciprofloxacin is a cyp3a4 and cyp1a2 inhibitor. coadministration with ciprofloxacin increased erlotinib exposure by 39% and increased the erlotinib cmax by 17%. ertugliflozin: (moderate) monitor blood glucose carefully when systemic quinolones and antidiabetic agents, including sglt2 inhibitors, are coadministered. Find patient medical information for cipro i.v. intravenous on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings.